In accordance with the experiments performed with healthy donor PBL and MCF-7 cells, a contribution to the anti-tumor response was provided by CD3-/CD56+ NK cells, which exhibited vigorous degranulation activity and IFN-γ production in response to primary breast tumor cells. The gene discussed is NCAM1; the disease is neoplasm.